Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin analogues.

Simon R Heller1

  • 1University of Sheffield, Clinical Sciences Centre, Northern General Hospital, UK. s.heller@sheffield.ac.uk

Current Medical Research and Opinion
|October 9, 2002
PubMed
Summary
This summary is machine-generated.

New insulin analogues offer faster absorption and potentially better glycemic control. While clinical benefits are modest, they significantly reduce severe nocturnal hypoglycemia in tightly controlled diabetes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrocardiograpic responses during spontaneous hypoglycaemia in people with type 1 diabetes and impaired awareness of hypoglycaemia.

Diabetic medicine : a journal of the British Diabetic Association·2025
Same author

Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational real-world study.

Diabetologia·2024
Same author

Acceptability and psychometric properties of four scales assessing the impact of Type 2 diabetes on quality of life-Results of 'YourSAY: Quality of Life'.

Diabetic medicine : a journal of the British Diabetic Association·2024
Same author

Perceptions of adults with type 1 diabetes toward diabetes-specific quality of life measures: a survey-based qualitative exploration.

Health and quality of life outcomes·2024
Same author

From educator to facilitator: Healthcare professionals' experiences of, and views about, delivering a type 1 diabetes structured education programme (DAFNEplus ) informed by behavioural science.

Diabetic medicine : a journal of the British Diabetic Association·2024
Same author

The type 1 diabetes grand challenge: The potential for transformative impact from the largest ever investment, £50 million and collaborative thinking across the UK.

Diabetic medicine : a journal of the British Diabetic Association·2024
Same journal

Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Jordan: epidemiology, trends, determinants, and clinical outcomes.

Current medical research and opinion·2026
Same journal

RSV disease and vaccination knowledge, attitudes, and practices among US adults: a 2024-2025 RSV season survey.

Current medical research and opinion·2026
Same journal

Clinical and healthcare resource utilization outcomes following revision knee arthroplasty with and without a gradually reducing radius revision knee system.

Current medical research and opinion·2026
Same journal

Medication adherence measurement methods and their reported relationship with medication safety outcomes: a scoping review.

Current medical research and opinion·2026
Same journal

BMI response to dapagliflozin with or without semaglutide across obesity classes: a real-world observational study conducted in Saudi Arabia.

Current medical research and opinion·2026
Same journal

Comparative efficacy of tislelizumab + FOLFOX or CAPOX for gastric/gastroesophageal junction adenocarcinoma: an exploratory matching-adjusted indirect comparison.

Current medical research and opinion·2026
See all related articles

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Intensive insulin therapy, following the Diabetes Control and Complications Trial, revealed limitations of conventional insulin.
  • Conventional insulins pose risks of hypoglycemia due to delayed absorption and peaked action.

Purpose of the Study:

  • To evaluate the efficacy and safety of rapid-acting insulin analogues (lispro and aspart) compared to conventional human insulin.
  • To explore the potential benefits of new long-acting insulin analogues (glargine, detemir) and analogue combinations.

Main Methods:

  • Comparison of absorption profiles and post-injection concentrations of insulin lispro and aspart versus conventional human insulin.
  • Review of clinical trial data assessing glycemic control (HbA1c) and hypoglycemic risk.

Main Results:

Related Experiment Videos

  • Rapid-acting analogues show faster absorption and higher post-injection concentrations, leading to better post-prandial glucose reduction.
  • Clinical trials demonstrated modest improvements in HbA1c and minor reductions in overall hypoglycemia risk.
  • A significant reduction in severe nocturnal hypoglycemia was observed with analogue use in tightly controlled diabetes.

Conclusions:

  • Rapid-acting insulin analogues offer a more physiological action profile compared to conventional insulin.
  • While overall glycemic control benefits are modest, analogues are crucial for reducing severe nocturnal hypoglycemia.
  • The combination of rapid and long-acting analogues holds promise for achieving tight glycemic control without increased hypoglycemia risk.